Oncorus to Present at Upcoming Jefferies Virtual Healthcare Conference
May 26 2021 - 7:00AM
Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company
focused on driving innovation to transform outcomes for cancer
patients, today announced that its President and Chief Executive
Officer, Theodore (Ted) Ashburn, M.D., Ph.D., will present at the
upcoming Jefferies Virtual Healthcare Conference on Wednesday, June
2, 2021 at 2:00 p.m. ET.
A live webcast of the presentation will be
available under the Investors & Media section of Oncorus’
website
at https://investors.oncorus.com/events-and-presentations. A
replay of the presentation will be archived on Oncorus’ site for 30
days following the event.
About Oncorus
At Oncorus, we are focused on driving innovation
to deliver next-generation viral immunotherapies to transform
outcomes for cancer patients. We are advancing a portfolio of
intratumorally and intravenously administered viral immunotherapies
for multiple indications with significant unmet needs based on our
oncolytic Herpes Simplex Virus (oHSV) Platform and Synthetic Virus
Platform. Designed to deliver next-generation viral immunotherapy
impact, our oHSV platform improves upon key characteristics of this
therapeutic class to enhance potency without sacrificing safety,
including greater capacity to encode transgenes to drive systemic
immunostimulatory activity, retention of full replication
competency to enable high tumor-killing potency, and orthogonal
safety strategies to restrict viral activity in tumor cells. Our
lead oHSV program, ONCR-177, is designed to be directly
administered into a tumor, resulting in high local concentrations
of the therapeutic agent, as well as low systemic exposure to the
therapy, which we believe could potentially limit systemic
toxicities. Please visit www.oncorus.com to learn more.
Media Contact:Liz
Meloneliz@scientpr.com617-256-6622
Oncorus (NASDAQ:ONCR)
Historical Stock Chart
From May 2024 to Jun 2024
Oncorus (NASDAQ:ONCR)
Historical Stock Chart
From Jun 2023 to Jun 2024